Publications
5543 Results
- Journal / Conference
- New England Journal of Medicine Feb 9;388(6):489-498
- Year
- 2023
- Research Committee(s)
- Lung
- PMID
- PMID36780674
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer
- Journal / Conference
- Journal of the National Cancer Institute Jan 10;115(1):21-28
- Year
- 2023
- Research Committee(s)
- Symptom Management and Survivorship
- PMID
- PMID36266760
- PMC
- PMC9830479
Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials
- Journal / Conference
- Scientific Reports Apr 12;13(1):5968. doi: 10.1038/s41598-023-31840-0
- Year
- 2023
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID37045850
- PMC
- PMC10097673
- Study Number(s)
- S0000
Application of Mendelian randomization to explore the causal role of the human gut microbiome in colorectal cancer
- Journal / Conference
- European Urology Oncology Apr 20;S2588-9311(23)00074-3
- Year
- 2023
- Research Committee(s)
- Genitourinary
- PMID
- PMID37087309
- PMC
- PMC10587361
- Study Number(s)
- S1314
Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314
- Journal / Conference
- Journal of the National Cancer Institute Jun 8;115(6):703-711
- Year
- 2023
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID36946291
- PMC
- PMC10248838
- Study Number(s)
- S1204
Risk Prediction of Hepatitis B or C or HIV Among Newly Diagnosed Cancer Patients
- Journal / Conference
- New England Journal of Medicine May 4;388(18):1645-1656
- Year
- 2023
- Research Committee(s)
- Breast and Cancer Survivorship
- PMID
- PMID37133584
- PMC
- PMC10358451
- Study Number(s)
- CTSU/A221405
Interrupting Endocrine Therapy to Attempt Pregnancy After Breast Cancer
- Journal / Conference
- JCO Oncology Practice Feb;19(2):Feb;19(2):
- Year
- 2023
- PMID
- PMID36480776
Do I Know You? Patient Privacy and Consent in the Age of Social Media
- Journal / Conference
- J Clin Oncol 41, 2023 (suppl 6; abstr TPS277); ASCO GU Cancers Symposium (Feb 16-18, 2023, San Francisco, CA), poster
- Year
- 2023
- Research Committee(s)
- Genitourinary
Alliance A031902 (CASPAR): A randomized, phase 3 trial of enzalutamide (ENZ) with rucaparib (RUCA)/placebo (PBO) in first-line metastatic castration-resistant prostate cancer (mCRPC)
- Journal / Conference
- Society for Clinical Trials (May 21-24, 2023, Baltimore, MD), poster
- Year
- 2023
- Research Committee(s)
- Cancer Care Delivery
Evaluating the impact of stratification, sample size, and randomization ratio on the power of randomized Phase 2 clinical trials
- Journal / Conference
- J Clin Oncol 41, 2023 (suppl 16; abstr TPS4198); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), TIP poster session
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S2001